Rat Anti-ADAM10 Recombinant Antibody (V2-179741) (CBMAB-A1103-YC)


(A) Representative images of WT and ADAM10fl/fl secondary neurospheres from YFP sorted cells. (B) Analysis of WT and ADAM10fl/fl YFP+ sorted cells in vitro demonstrated an increased formation of neurospheres following secondary (*P = 0.0444) and tertiary (*P = 0.0306) passaging. 2° NS: 2° neurosphere (passage 1); 3° NS: 3° neurosphere (passage 2). (C) Analysis of sphere diameter demonstrated YFP+ADAM10fl/fl sorted cells were smaller compared to WT spheres (WT vs. ADAM10fl/fl YFP sorted cells, ***P = 0.0001). (D) Bins of neurosphere size showed WT spheres with wider diameter while more of the ADAM10fl/fl spheres were 1-30 μm in size (WT vs. ADAM10fl/fl YFP sorted cells, **P = 0.004 and *P = 0.013 for 1-30 μm and 50-100 μm, respectively; P = 0.478 and 0.328 for 30-50 μm and 100+ μm, respectively). (E) Representative images from Nestin-YFP (green) sorted cells treated with BrdU 2 hours before processing for YFP and BrdU. (F) Quantification in E showed a decrease in the percentage of YFP+BrdU+/total YFP+ cells. In total, 427 WT and 727 ADAM10fl/fl YFP+ cells were quantified. WT vs. ADAM10fl/fl cell, *P = 0.0134. (G, H) Representative images of 2° NS-derived cells after in vitro differentiation stained for MAP2 (red) (G) and Nestin (red) (H). (I) Representative images of WT and ADAM10fl/fl NSCs from GFAP::GFP mice differentiated in vitro. Stained for Nestin (red) similarly demonstrate increased GFAP::GFP+ cells (green) co-expressing the NSC marker Nestin (arrowheads). (J) Quantification of YFP sorted cell differentiation shows the percentage of MAP2+ (left) cells and Nestin+ cells (right) normalized over DAPI. The numbers are expressed as a ratio. 5804 and 5475 WT and ADAM10fl/fl cells were counted, respectively (MAP2+ cells: 0.51 ± 0.08 of controls, *P = 0.0239; Nestin+ cells: 2.17 ± 0.48 of controls, *P = 0.043). Scale bars: 50 μm in E, G, I, 10 μm in H. n = 3. Statistical analysis with Student's unpaired t-test. Error bars represent the mean ± SEM. ADAM10: A disintegrin and metalloproteinase 10; BrdU: bromodeoxyuridine; GFAP: glial fibrillary acidic protein; MAP2: microtubule-associated protein 2; NSC: neural stem cell; WT: wild-type; YFP: yellow fluorescent protein. ...View More



Basic Information
Application | Note |
FC | 2.5 μg/10^6 cells |
WB | 1 μg/ml |
Formulations & Storage [For reference only, actual COA shall prevail!]
Target
(Microbial infection) Promotes the cytotoxic activity of S.aureus hly by binding to the toxin at zonula adherens and promoting formation of toxin pores.
Amyloid-beta formation
Amyloid fibril formation
Amyloid precursor protein catabolic process
Cell-cell signaling
Cellular protein metabolic process
Cochlea development
Constitutive protein ectodomain proteolysis
Extracellular matrix disassembly
Integrin-mediated signaling pathway
In utero embryonic development
Membrane protein ectodomain proteolysis
Monocyte activation
Negative regulation of apoptotic process
Negative regulation of cell adhesion
Negative regulation of cell cycle arrest
Negative regulation of gene expression
Neutrophil degranulation
Notch receptor processing, ligand-dependent
Notch signaling pathway
Pore complex assembly
Positive regulation of apoptotic process
Positive regulation of cell growth
Positive regulation of cell migration
Positive regulation of cell population proliferation
Positive regulation of T cell chemotaxis
Postsynapse organization
Post-translational protein modification
Protein phosphorylation
Protein processing
Regulation of dendritic spine morphogenesis
Regulation of neurotransmitter receptor localization to postsynaptic specialization membrane
Regulation of Notch signaling pathway
Regulation of vasculature development
Response to antineoplastic agent
Response to tumor necrosis factor
Spermatogenesis
Toxin transport
Alzheimer disease 18 (AD18): A late-onset form of Alzheimer disease. Alzheimer disease is a neurodegenerative disorder characterized by progressive dementia, loss of cognitive abilities, and deposition of fibrillar amyloid proteins as intraneuronal neurofibrillary tangles, extracellular amyloid plaques and vascular amyloid deposits. The major constituents of these plaques are neurotoxic amyloid-beta protein 40 and amyloid-beta protein 42, that are produced by the proteolysis of the transmembrane APP protein. The cytotoxic C-terminal fragments (CTFs) and the caspase-cleaved products, such as C31, are also implicated in neuronal death.
Helical: 673-693 aa
Cytoplasmic: 694-748 aa
Submit a review and get a Coupon or an Amazon gift card. 20% off Coupon

Submit a review

Please try the standard protocols which include: protocols, troubleshooting and guide.
Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme-Linked Immunospot (ELISpot)
Proteogenomics
Other Protocols
Related Products
Mouse Anti-ADAM10 Recombinant Antibody (CBT3602) (CAT#: V2LY-0625-LY1439)
Mouse Anti-ADAM10 Recombinant Antibody (V2-607122) (CAT#: CBMAB-C9454-LY)
Rat Anti-ADAM10 Recombinant Antibody (V2-179746) (CAT#: CBMAB-A1108-YC)
Rabbit Anti-ADAM10 Recombinant Antibody (V2-6078) (CAT#: CBMAB-0023CQ)
Mouse Anti-ADAM10 Recombinant Antibody (V2-179747) (CAT#: CBMAB-A1109-YC)
Mouse Anti-ADAM10 Recombinant Antibody (V2-179742) (CAT#: CBMAB-A1104-YC)
Custom Antibody Labeling
We also offer labeled antibodies developed using our catalog antibody products and nonfluorescent conjugates (HRP, AP, Biotin, etc.) or fluorescent conjugates (Alexa Fluor, FITC, TRITC, Rhodamine, Texas Red, R-PE, APC, Qdot Probes, Pacific Dyes, etc.).
Online InquiryContact us
